title: Incidence and etiology of hepatic dysfunction in heart transplant recipients receiving a cyclosporine-based triple immunosuppressive therapy.
authors.affiliation: Oklahoma Transplantation Institute, Baptist Medical Center, Oklahoma City 73112.
authors.forename: A
authors.initials: A
authors.lastname: Jazzar
authors.forename: S
authors.initials: S
authors.lastname: Fagiuoli
authors.forename: P
authors.initials: P
authors.lastname: Caraceni
authors.forename: S
authors.initials: S
authors.lastname: Deal
authors.forename: H I
authors.initials: HI
authors.lastname: Wright
authors.forename: S
authors.initials: S
authors.lastname: Sisson
authors.forename: J
authors.initials: J
authors.lastname: Gavaler
authors.forename: D H
authors.initials: DH
authors.lastname: Van Thiel
authors.forename: N
authors.initials: N
authors.lastname: Zuhdi
authors.forename: D K
authors.initials: DK
authors.lastname: Cooper
mesh_terms: D001379:Azathioprine / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury; D016572:Cyclosporine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008107:Liver Diseases / Q000453:epidemiology*; D008111:Liver Function Tests; D013997:Time Factors
chemical_list: D016572:Cyclosporine; D001379:Azathioprine